acasti pharma stock price target

1160 - 1160 Acasti Pharma 1160 0040 357 General Chart News Analysis Financials Technical Forum Technical Analysis Candlestick. The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 500 with a high estimate of 500 and a low estimate of 500.

Acasti Pharma Inc Awaiting Business Review Outcome After Capre Drug Trial Disappointment

Acasti Pharma Schedules Fiscal Year 2022 Business Update Conference Call Acasti Pharma stock rating What analysts recommend for ACST stock on a scale from 1 buy to 5 sell.

. On the other hand Acasti Pharmas target price is what analysts think the stock is worth or could sell for in the future. ACST 086 DJIA 023 Russell 2K -079 Health CareLife Sciences -023 Overview Profile Financials Income Statement Balance Sheet Cash Flow Research Ratings Historical Prices Options Advanced. On 2022-07-08 Acasti Pharma ACST-X stock closed at a price of 114.

Modernas stock rose 28X in the past 2 years are these biotech picks next. The Acasti Pharma stock price fell by -213 on the last day Friday 22nd Jul 2022 from 088 to 086. The median estimate represents a.

Buy Sell 1 Acasti Pharma price target What analysts think ACST will be worth Low 082 High 6 Current 085 Target 6 Events List of events that could affect ACST stock. Acasti Pharma stock price target cut to 2 from 8 at B. 2870 Owned Unlock Rating.

Based On Fundamental Analysis. Subarachnoid Hemorrhage SAH Ataxia Telangiectasia A-T and Postherpetic Neuralgia PHN. What are analysts forecasts for Acasti Pharma stock.

Evolution of the average Target Price on ACASTI PHARMA INC. The average Acasti Pharma Inc. Get the latest Acasti Pharma stock price and detailed information including ACST news historical charts and realtime prices.

Is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. Stock forecast for 2032 10 year 6 predictions are offered for each month of 2032 with average Acasti Pharma Inc. The price has fallen in 7 of the last 10 days and is down by -41 for this period.

The current price of Acasti Pharma is the price at which Acasti Pharma is currently trading. ACST stock quote history news and other vital information to help you with your stock trading and investing. Stock Price Targets Yearly Numbers Estimates ACST will report 2023 earnings on 06282023 EPS Estimate 2022 2023 2024 2025 -1 -05 0 Quarterly Numbers Actuals Estimates ACST will report Q4 2023.

To contextualize these metrics consider that out of Healthcare stocks Acasti Pharma Incs average analyst price target is greater than 1269 of them. Stock forecast 2030 represents a 39502 increase from the last price of 121000003814697. Ad Our Strong Buys Double the SP.

He sees a 10 target price if the result is good and all goes well. Stock quotes are provided by Factset Morningstar and SP Capital IQ. BUY Acasti Pharma ACST-X 28112019 at 1200am.

Acasti Pharmas current and average target prices are 083 and 600 respectively. During the day the stock fluctuated 409 from a day low at 086 to a day high of 089. For Acasti Pharma Inc.

14 2020 at 856 am. Ad Biotech is becoming one of the best new sectors for investing if you know where to look. ACST analyst stock forecast price target and recommendation trends with in-depth analysis from research reports.

3 Dividend Stocks To Generate Easy Passive Income. What is Acasti Pharma stock price. In depth view into Acasti Pharma Price Target including historical data from 2011 charts stats and industry comps.

The Wall Street analyst predicted that Acasti Pharma s share price could reach 600 by Dec 22 2022. Analyst Recommendations on ACASTI PHARMA INC. ACST Stock Trend The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled.

Last 18 months Recommendations Chart ACASTI PHARMA INC. Ad 3 Dividend stocks tailored picked to thrive during the upcoming crash. Find the latest Acasti Pharma Inc.

Shutterstock Today Oppenheimer initiated coverage on. The Company is targeting three underserved orphan diseases. Quite likes the company.

ACST stock has declined by more than 50 year to date YTD vastly trailing the SP 500s return of 26. Acasti Pharma Inc. In the context of Healthcare stocks Acasti Pharma Incs upside potential average analyst target price relative to current price is greater than 15107 of them.

Find the latest Acasti Pharma Inc. According to 1 Wall Street analyst that have issued a 1 year ACST price target the average ACST price target is 600 with the highest ACST stock price forecast at 600 and the lowest ACST stock price forecast at 600. ET by Tomi Kilgore Acasti Pharma downgraded to neutral from buy at B.

Target Price consensus revisions. Stock forecast of 646 a high forecast of 646 and a low forecast of 645. The 1 analysts offering price forecasts for Acasti Pharma have a median target of 600 with a high estimate of 600 and a.

Consumer Products Robert McWhirter. Given the current short-term trend the stock is expected to fall -2155 during the next 3 months and with a 90 probability hold a price between 064 and 077 at the end of this 3-month period. Acasti Pharma Inc - Ordinary Shares - Class A NASDAQ Updated Jul 22 2022 1158 PM.

Pin By Satyajit Dasgupta On Information Is Wealth Specialty Chemicals Analysis Global Economy